In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

For decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — ...

For decades, chronic respiratory diseases (CRDs) such as asthma and chronic obstructive pulmonary disease (COPD) have been ...

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

Chronic respiratory diseases are among the top causes of death and disability worldwide, yet receive little political or ...

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Lupin Limited has received recommendations from the Subject Expert Committee (SEC) under the Central Drugs Standard Control ...

Telemedicine-mediated follow-up for advanced chronic obstructive pulmonary disease potentially improves quality of life and ...

Content by Health System. With Asthma Peak Week typically during the middle of September, now is a great time to learn the ...

Lupin Limited has received recommendations from the Subject Expert Committee, under the Central Drugs Standard Control ...

A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.